基本信息
浏览量:3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Biography
Farida Ahangari is an Assistant Professor in the Pulmonary, Critical Care and Sleep Medicine at Yale. Her main interest is to understand the pathogenesis of pulmonary fibrosis and the metabolic regulatory counterpart of this fatal disease. Her studies focus on the role of metabolic reprogramming in the pathogenesis of chronic lung diseases and aim to test targeted cell specific therapy using microRNA/noncoding RNAs for different diseases.
Dr. Ahangari trained as M.D. from Iran University of Medical Sciences in Tehran and have spent most of her professional life in medical research afterward. She started her research training in one of the world’s premier cancer groups, the Queensland Institute of Medical Research in Australia (QIMR). During this research fellowship, she learned about the role of ATM (Ataxia Telangiectasia Mutated protein) in oxidative stress and DNA damage response in cancer and mastered in primary Purkinje cell isolation from newborn mice to study metabolic changes, tissue transplant and small survival surgery on different murine cancer models.
After arriving at Yale in 2008, she joined Professor Jack Elias’s lab in the Pulmonary section as a postdoctoral fellow, focusing on various animal and cellular models of lung inflammation and fibrosis, as well as studying the link between metabolism and lung biology. She joined Professor Naftali Kaminski’s lab at Yale in 2014 as a research scientist to explore the translational aspects of lung diseases. In the past few years, she has led a variety of multicenter collaborative projects, including understanding the networks underlying lung development and transcriptional regulatory model of fibrosis progression in the human lung.
Her career focus will be the translation of the mechanistic research findings into the clinic to treat the chronic lung diseases including IPF.
Farida Ahangari is an Assistant Professor in the Pulmonary, Critical Care and Sleep Medicine at Yale. Her main interest is to understand the pathogenesis of pulmonary fibrosis and the metabolic regulatory counterpart of this fatal disease. Her studies focus on the role of metabolic reprogramming in the pathogenesis of chronic lung diseases and aim to test targeted cell specific therapy using microRNA/noncoding RNAs for different diseases.
Dr. Ahangari trained as M.D. from Iran University of Medical Sciences in Tehran and have spent most of her professional life in medical research afterward. She started her research training in one of the world’s premier cancer groups, the Queensland Institute of Medical Research in Australia (QIMR). During this research fellowship, she learned about the role of ATM (Ataxia Telangiectasia Mutated protein) in oxidative stress and DNA damage response in cancer and mastered in primary Purkinje cell isolation from newborn mice to study metabolic changes, tissue transplant and small survival surgery on different murine cancer models.
After arriving at Yale in 2008, she joined Professor Jack Elias’s lab in the Pulmonary section as a postdoctoral fellow, focusing on various animal and cellular models of lung inflammation and fibrosis, as well as studying the link between metabolism and lung biology. She joined Professor Naftali Kaminski’s lab at Yale in 2014 as a research scientist to explore the translational aspects of lung diseases. In the past few years, she has led a variety of multicenter collaborative projects, including understanding the networks underlying lung development and transcriptional regulatory model of fibrosis progression in the human lung.
Her career focus will be the translation of the mechanistic research findings into the clinic to treat the chronic lung diseases including IPF.
研究兴趣
论文共 107 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
B29. BIOMARKERS AND NEW THERAPEUTICS TARGETS IN LUNG FIBROSIS (2024)
J. Khoury,F. Ahangari,E.P. Manning,A. Justet,T. barnthaler, T. Adams, F. Necola,K.-D. Alysandratos, M.L. Beermann,D.N. Kotton,N. Kaminski
C28. MORE THAN MEET THE EYE: NOVEL INSIGHTS IN IPF PATHOGENESIS (2024)
Y. Yuan, L.K. Sharma, W. Tang,M.S.B. Raredon,F. Ahangari,J. Khoury, D.D. Wu,L.E. Niklason,N. Kaminski
B95. SURFING IN THE GREEN ROOM: DEFINING MOLECULAR MECHANISMS OF PULMONARY VASCULAR DISEASE (2024)
Amy Y Zhao,Avraham Unterman, Nebal S Abu Hussein,Prapti Sharma, Fadi Nekola,Jasper Flint,Xiting Yan,Taylor S Adams,Aurelien Justet,Tomokazu S Sumida,Jiayi Zhao,Jonas C Schupp,
American journal of respiratory and critical care medicine (2024)
S.-H. Kim,J. Nouws, J. Cooley,F. Ahangari,L. Leng,J.A. Elias,N. Kaminski, P. Lee, E. Redente,M.-J. Kang, H. Sun,E. Herzog,
B15. THE MACROPHAGE IN ALL ITS GLORY (2024)
Glenda Trujillo, Alicia Regueiro-Ren, Chunjian Liu,Buqu Hu, Ying Sun,Farida Ahangari, Vitoria Fiorini, Genta Ishikawa, Karam Al Jumaily, Johad Khoury, John McGovern, Chris J Lee,
American journal of respiratory and critical care medicine (2024)
Avraham Unterman,Amy Y Zhao, Nir Neumark,Jonas C Schupp,Farida Ahangari, Carlos Cosme,Prapti Sharma,Jasper Flint, Yan Stein, Changwan Ryu, Genta Ishikawa,Tomokazu S Sumida,
American journal of respiratory and critical care medicineno. 4 (2024): 484-496
SCIENCE ADVANCESno. 25 (2024): eadm9817-eadm9817
加载更多
作者统计
#Papers: 107
#Citation: 2762
H-Index: 19
G-Index: 52
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn